The UCL Movement Disorders Centre (MDC) brings together patients, clinicians, data, discovery research programmes and experimental medicine trials in order to make the next key breakthroughs for Parkinson’s disease, dystonia and other movement disorders. Through our world-class research, we aim to gain a better understanding of the causes, effects, biological mechanisms and treatment of movement disorders. Our members are UCL clinical academics and movement disorders specialist clinicians working across affiliated hospitals: University College London Hospital (UCLH), The National Hospital for Neurology and Neurosurgery at Queen Square and the Royal Free London Hospital.
The centre is part of the Department of Clinical and Movement Neurosciences of the UCL Queen Square Institute of Neurology. The Department undertakes world-leading basic and clinical research across the spectrum of movement disorders, their causes and treatments.
Funding
The UCL Movement Disorders Centre was established and is supported by funding from University College London Hospitals National Institute for Health Research (NIHR) Biomedical Research Centre (BRC).
MDC was selected to host The Edmond J. Safra Movement Disorders Fellowship (2019-2022), awarded by The Michael J. Fox Foundation.
The Janet Owens fellowships to develop new treatments for Parkinson's disease are funded by generous donation from Dr. Owens' family.
The MDC professional clinical research team was established and supported thanks to funding from the Edmond J. Safra Philanthropic Foundation (2018-2020).